GO | Name |
GO:0000139 | Golgi membrane |
GO:0000187 | obsolete activation of MAPK activity |
GO:0000785 | chromatin |
GO:0001664 | G protein-coupled receptor binding |
GO:0001933 | negative regulation of protein phosphorylation |
GO:0001934 | positive regulation of protein phosphorylation |
GO:0002031 | G protein-coupled receptor internalization |
GO:0002092 | positive regulation of receptor internalization |
GO:0003713 | transcription coactivator activity |
GO:0004857 | enzyme inhibitor activity |
GO:0005096 | GTPase activator activity |
GO:0005159 | insulin-like growth factor receptor binding |
GO:0005634 | nucleus |
GO:0005654 | nucleoplasm |
GO:0005737 | cytoplasm |
GO:0005765 | lysosomal membrane |
GO:0005768 | endosome |
GO:0005829 | cytosol |
GO:0005886 | plasma membrane |
GO:0005905 | clathrin-coated pit |
GO:0006357 | regulation of transcription by RNA polymerase II |
GO:0006511 | ubiquitin-dependent protein catabolic process |
GO:0006892 | post-Golgi vesicle-mediated transport |
GO:0007186 | G protein-coupled receptor signaling pathway |
GO:0008134 | transcription factor binding |
GO:0008284 | positive regulation of cell population proliferation |
GO:0014069 | postsynaptic density |
GO:0015031 | protein transport |
GO:0016323 | basolateral plasma membrane |
GO:0016567 | protein ubiquitination |
GO:0016573 | histone acetylation |
GO:0016604 | nuclear body |
GO:0030168 | platelet activation |
GO:0030331 | estrogen receptor binding |
GO:0030659 | cytoplasmic vesicle membrane |
GO:0031143 | pseudopodium |
GO:0031397 | negative regulation of protein ubiquitination |
GO:0031398 | positive regulation of protein ubiquitination |
GO:0031410 | cytoplasmic vesicle |
GO:0031625 | ubiquitin protein ligase binding |
GO:0031691 | alpha-1A adrenergic receptor binding |
GO:0031692 | alpha-1B adrenergic receptor binding |
GO:0031701 | angiotensin receptor binding |
GO:0031762 | follicle-stimulating hormone receptor binding |
GO:0031896 | V2 vasopressin receptor binding |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity |
GO:0032715 | negative regulation of interleukin-6 production |
GO:0032717 | negative regulation of interleukin-8 production |
GO:0034260 | negative regulation of GTPase activity |
GO:0034393 | positive regulation of smooth muscle cell apoptotic process |
GO:0035025 | positive regulation of Rho protein signal transduction |
GO:0035066 | positive regulation of histone acetylation |
GO:0035612 | AP-2 adaptor complex binding |
GO:0035615 | clathrin adaptor activity |
GO:0042493 | response to drug |
GO:0042699 | follicle-stimulating hormone signaling pathway |
GO:0043149 | stress fiber assembly |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:0043197 | dendritic spine |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0043524 | negative regulation of neuron apoptotic process |
GO:0044325 | transmembrane transporter binding |
GO:0045211 | postsynaptic membrane |
GO:0045309 | protein phosphorylated amino acid binding |
GO:0045746 | negative regulation of Notch signaling pathway |
GO:0045944 | positive regulation of transcription by RNA polymerase II |
GO:0061024 | membrane organization |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
GO:0090240 | positive regulation of histone H4 acetylation |
GO:1990763 | arrestin family protein binding |